Table Of Content

Journal of the Neurological Sciences, 106 (1991) 238-240 © 1991 Elsevier Science Publishers B.V. All rights reserved 0022-510X /91/$03.50 Author Index (Vol. 106) Abdella, M., see Elwan, O. (106) 75 Ferrer, I., Soriano, E., Tunén, T., Fonseca, M. and Guionnet, N. Agusti, M., see Graus, F. (106) 82 Parvalbumin immunoreactive neurons in normal human temporal Antoine, J.C., Tommasi, M., Boucheron, S., Convers, P., Laurent, B. neocortex and in patients with Alzheimer’s disease (106) 135 and Michel, D. Ferrier, I.N., see Cheng, A.V.T. (106) 50 Pathology of roots, spinal cord and brainstem in syringomyelia-like Fonseca, M., see Ferrer, I. (106) 135 syndrome of Tangier disease (106) 179 Frohman, E.M., Frohman, T.C., Gupta, S., De Fougerolles, A. and Antozzi, C., see Beghi, E. (106) 213 Van den Noort, S. Applegate, M.D., see Landfield, P.W. (106) 221 Expression of intercellular adhesion molecule 1 (ICAM-1) in Araki, T., Kato, H., Kogure, K. and Saito, T. Alzheimer’s disease (106) 105 Postischemic alteration of muscarinic acetylcholine, adenosine A , Frohman, T.C., see Frohman, E.M. (106) 105 and calcium antagonist binding sites in selectively vulnerable Fujihara, K., see Kira, J.-i. (106) 41 areas: an autoradiographic study of gerbil brain (106) 206 Fujita, H., see Ihara, Y. (106) 10 Arimura, K., see Higuchi, I. (106) 60 Fukunaga, H., see Higuchi, I. (106) 60 Fukuyama, H., Harada, K., Yamauchi, H., Miyoshi, T., Yamaguchi, Bakr El Bayad, A., see Elwan, O. (106) 75 S., Kimura, J., Kameyama, M., Senda, M., Yonekura, Y. and Baser, S.M., see Polinsky, R.J. (106) 96 Konishi, J. Batocchi, A.P., see Beghi, E. (106) 213 Coronal reconstruction images of glucose metabolism in Beghi, E., Antozzi, C., Batocchi, A.P., Cornelio, F., Cosi, V., Evoli, Alzheimer’s disease (106) 128 A., Lombardi, M., Mantegazza, R., Monticelli, M.L., Piccolo, G., Tonali, P., Trevisan, D. ana Zarrelli, M. Gheuens, J., see Truyen, L. (106) 35 Prognosis of myasthenia gravis: a multicenter follow-up study of Goto, I., see Kira, J.-i. (106) 41 844 patients (106) 213 Goto, Y.-i., see Matsuoka, T. (106) 193 Blansjaar, B.A., Zwang, R. and Blijenberg, B.G. Graus, F., Illa, I., Agusti, M., Ribalta, T., Cruz-Sanchez, F. and No transketolase abnormalities in Wernicke—Korsakoff patients Juarez, C. (106) 88 Effect of intraventricular injection of an anti-Purkinje cell anti- Blight, A.R. body (anti-Yo) in a guinea pig model (106) 82 Morphometric analysis of blood vessels in chronic experimental Guionnet, N., see Ferrer, I. (106) 135 spinal cord injury: hypervascularity and recovery of function (106) Gumpert, E.J.W., see Kandler, R.H. (106) 25 158 Gumpert, E.J.W., see Kandler, R.H. (106) 31 Blijenberg, B.G., see Blansjaar, B.A. (106) 88 Gupta, S., see Frohman, E.M. (106) 105 Boucheron, S., see Antoine, J.C. (106) 179 Hamdy, S., see Elwan, O. (106) 75 Brass, L.M., see Vollmer, T.L. (106) 153 Harada, K., see Fukuyama, H. (106) 128 Caponnetto, C., see Tabaton, M. (106) 123 Hasuo, K., see Kira, J.-i. (106) 41 Cheng, A.V.T., Ferrier, I.N., Morris, C.M., Jabeen, S., Sahgal, A., Hayashi, M., see Yokota, T. (106) 175 McKeith, 1.G., Edwardson, J.A., Perry, R.H. and Perry, E.K. Higuchi, I., Nerenberg, M., Ijichi, T., Fukunaga, H., Arimura, K., Cortical serotonin-S, receptor binding in Lewy body dementia, Usuki, F., Kuriyama, M. and Osame, M. Alzheimer’s and Parkinson’s diseases (106) 50 Vacuolar myositis with expression of both MHC class I and class Chu, C.-C., see Chu, N.-S. (106) 1 II antigens on skeletal muscle fibers (106) 60 Chu, N.-S., Chu, C.-C., Tu, S.-C. and Huang, C.-C. Hojeberg, B., Ingemarsson, R., Kristensson, K., Lycke, E. and Ols- EEG spectral analysis and topographic mapping in Wilson’s son, T. disease (106) 1 A monoclonal antibody against HSV type 1 ribonucleotide reduc- Convers, P., see Antoine, J.C. (106) 179 tase cross-reacts with the P, protein of peripheral nerve myelin Cornelio, F., see Beghi, E. (106) 213 (106) 91 Cosi, V., see Beghi, E. (106) 213 Huang, C.-C., see Chu, N.-S. (106) 1 Cruz-Sanchez, F., see Graus, F. (106) 82 Ihara, Y., Nobukuni, K., Namba, R., Kamisaka, K., Kibata, M., Dahlstrém, A., see Polinsky, R.J. (106) 96 Kajinami, K., Fujita, H., Mabuchi, H., Shirabe, T., Ohshima, Davies-Jones, G.A.B., see Kandler, R.H. (106) 25 K.-I., Mori, A. and Kodama, H. Davies-Jones, G.A.B., see Kandler, R.H. (106) 31 A family of familial hypercholesterolemia with cerebral infarction De Fougerolles, A., see Frohman, E.M. (106) 105 and without coronary heart disease. An unusual case with corneal opacity, polyneuropathy and carpal tunnel syndrome in the fam- Edwardson, J.A., see Cheng, A.V.T. (106) 50 ily: therapy with probucol and tocopherol nicotinate (106) 10 Elwan, O., Abdella, M., Bakr El Bayad, A. and Hamdy, S. Ijichi, T., see Higuchi, I. (106) 60 Hormonal changes in headache patients (106) 75 Illa, 1., see Graus, F. (106) 82 Evoli, A., see Beghi, E. (106) 213 Ince, P., Irving, D., MacArthur, F. and Perry, R.H. Journal of the Neurological Sciences, 106 (1991) 238-240 © 1991 Elsevier Science Publishers B.V. All rights reserved 0022-510X /91/$03.50 Author Index (Vol. 106) Abdella, M., see Elwan, O. (106) 75 Ferrer, I., Soriano, E., Tunén, T., Fonseca, M. and Guionnet, N. Agusti, M., see Graus, F. (106) 82 Parvalbumin immunoreactive neurons in normal human temporal Antoine, J.C., Tommasi, M., Boucheron, S., Convers, P., Laurent, B. neocortex and in patients with Alzheimer’s disease (106) 135 and Michel, D. Ferrier, I.N., see Cheng, A.V.T. (106) 50 Pathology of roots, spinal cord and brainstem in syringomyelia-like Fonseca, M., see Ferrer, I. (106) 135 syndrome of Tangier disease (106) 179 Frohman, E.M., Frohman, T.C., Gupta, S., De Fougerolles, A. and Antozzi, C., see Beghi, E. (106) 213 Van den Noort, S. Applegate, M.D., see Landfield, P.W. (106) 221 Expression of intercellular adhesion molecule 1 (ICAM-1) in Araki, T., Kato, H., Kogure, K. and Saito, T. Alzheimer’s disease (106) 105 Postischemic alteration of muscarinic acetylcholine, adenosine A , Frohman, T.C., see Frohman, E.M. (106) 105 and calcium antagonist binding sites in selectively vulnerable Fujihara, K., see Kira, J.-i. (106) 41 areas: an autoradiographic study of gerbil brain (106) 206 Fujita, H., see Ihara, Y. (106) 10 Arimura, K., see Higuchi, I. (106) 60 Fukunaga, H., see Higuchi, I. (106) 60 Fukuyama, H., Harada, K., Yamauchi, H., Miyoshi, T., Yamaguchi, Bakr El Bayad, A., see Elwan, O. (106) 75 S., Kimura, J., Kameyama, M., Senda, M., Yonekura, Y. and Baser, S.M., see Polinsky, R.J. (106) 96 Konishi, J. Batocchi, A.P., see Beghi, E. (106) 213 Coronal reconstruction images of glucose metabolism in Beghi, E., Antozzi, C., Batocchi, A.P., Cornelio, F., Cosi, V., Evoli, Alzheimer’s disease (106) 128 A., Lombardi, M., Mantegazza, R., Monticelli, M.L., Piccolo, G., Tonali, P., Trevisan, D. ana Zarrelli, M. Gheuens, J., see Truyen, L. (106) 35 Prognosis of myasthenia gravis: a multicenter follow-up study of Goto, I., see Kira, J.-i. (106) 41 844 patients (106) 213 Goto, Y.-i., see Matsuoka, T. (106) 193 Blansjaar, B.A., Zwang, R. and Blijenberg, B.G. Graus, F., Illa, I., Agusti, M., Ribalta, T., Cruz-Sanchez, F. and No transketolase abnormalities in Wernicke—Korsakoff patients Juarez, C. (106) 88 Effect of intraventricular injection of an anti-Purkinje cell anti- Blight, A.R. body (anti-Yo) in a guinea pig model (106) 82 Morphometric analysis of blood vessels in chronic experimental Guionnet, N., see Ferrer, I. (106) 135 spinal cord injury: hypervascularity and recovery of function (106) Gumpert, E.J.W., see Kandler, R.H. (106) 25 158 Gumpert, E.J.W., see Kandler, R.H. (106) 31 Blijenberg, B.G., see Blansjaar, B.A. (106) 88 Gupta, S., see Frohman, E.M. (106) 105 Boucheron, S., see Antoine, J.C. (106) 179 Hamdy, S., see Elwan, O. (106) 75 Brass, L.M., see Vollmer, T.L. (106) 153 Harada, K., see Fukuyama, H. (106) 128 Caponnetto, C., see Tabaton, M. (106) 123 Hasuo, K., see Kira, J.-i. (106) 41 Cheng, A.V.T., Ferrier, I.N., Morris, C.M., Jabeen, S., Sahgal, A., Hayashi, M., see Yokota, T. (106) 175 McKeith, 1.G., Edwardson, J.A., Perry, R.H. and Perry, E.K. Higuchi, I., Nerenberg, M., Ijichi, T., Fukunaga, H., Arimura, K., Cortical serotonin-S, receptor binding in Lewy body dementia, Usuki, F., Kuriyama, M. and Osame, M. Alzheimer’s and Parkinson’s diseases (106) 50 Vacuolar myositis with expression of both MHC class I and class Chu, C.-C., see Chu, N.-S. (106) 1 II antigens on skeletal muscle fibers (106) 60 Chu, N.-S., Chu, C.-C., Tu, S.-C. and Huang, C.-C. Hojeberg, B., Ingemarsson, R., Kristensson, K., Lycke, E. and Ols- EEG spectral analysis and topographic mapping in Wilson’s son, T. disease (106) 1 A monoclonal antibody against HSV type 1 ribonucleotide reduc- Convers, P., see Antoine, J.C. (106) 179 tase cross-reacts with the P, protein of peripheral nerve myelin Cornelio, F., see Beghi, E. (106) 213 (106) 91 Cosi, V., see Beghi, E. (106) 213 Huang, C.-C., see Chu, N.-S. (106) 1 Cruz-Sanchez, F., see Graus, F. (106) 82 Ihara, Y., Nobukuni, K., Namba, R., Kamisaka, K., Kibata, M., Dahlstrém, A., see Polinsky, R.J. (106) 96 Kajinami, K., Fujita, H., Mabuchi, H., Shirabe, T., Ohshima, Davies-Jones, G.A.B., see Kandler, R.H. (106) 25 K.-I., Mori, A. and Kodama, H. Davies-Jones, G.A.B., see Kandler, R.H. (106) 31 A family of familial hypercholesterolemia with cerebral infarction De Fougerolles, A., see Frohman, E.M. (106) 105 and without coronary heart disease. An unusual case with corneal opacity, polyneuropathy and carpal tunnel syndrome in the fam- Edwardson, J.A., see Cheng, A.V.T. (106) 50 ily: therapy with probucol and tocopherol nicotinate (106) 10 Elwan, O., Abdella, M., Bakr El Bayad, A. and Hamdy, S. Ijichi, T., see Higuchi, I. (106) 60 Hormonal changes in headache patients (106) 75 Illa, 1., see Graus, F. (106) 82 Evoli, A., see Beghi, E. (106) 213 Ince, P., Irving, D., MacArthur, F. and Perry, R.H. Quantitative neuropathological study of Alzheimer-type pathol- Morris, C.M., see Cheng, A.V.T. (106) 50 ogy in the hippocampus: comparison of senile dementia of Mutamba, A., see Julu, P.O.O. (106) 56 Alzheimer type, senile dementia of Lewy body type, Parkinson’s disease and non-demented elderly control patients (106) 142 Nagasato, K., see Shibayama, K. (106) 186 Ingemarsson, R., see Hdjeberg, B. (106) 91 Nagataki, S., see Shibayama, K. (106) 186 Irving, D., see Ince, P. (106) 142 Nakamura, T., see Shibayama, K. (106) 186 Itoyama, Y., see Kira, J.-i. (106) 41 Namba, R., see Ihara, Y. (106) 10 Naylor, C.E., see Landfield, P.W. (106) 221 Jabeen, S., see Cheng, A.V.T. (106) 50 Nerenberg, M., see Higuchi, I. (106) 60 Jarratt, J.A., see Kandler, R.H. (106) 25 Nishimura, M., Satoh, K.-i., Suga, M. and Oda, M. Jarratt, J.A., see Kandler, R.H. (106) 31 Cerebral angio- and neuro-Behcet’s syndrome: neuroradiological Juarez, C., see Graus, F. (106) 82 and pathological study of one case (106) 19 Julu, P.O.O. and Mutamba, A. Nobukuni, K., see Ihara, Y. (106) 10 Comparison of short-term effects of insulin and essential fatty Nonaka, I., see Matsuoka, T. (106) 193 acids on the slowed nerve conduction of streptozotocin diabetes in rats (106) 56 Oda, M., see Nishimura, M. (106) 19 Ohman, S., Kajinami, K., see Ihara, Y. (106) 10 Is isoelectric focusing a “gold standard” for evaluation of formu- Kameyama, M., see Fukuyama, H. (106) 128 las for calculation of intrathecal immunoglobulin synthesis? (106) Kamisaka, K., see Ihara, Y. (106) 10 230 Kandler, R.H., Jarratt, J.A., Davies-Jones, G.A.B., Gumpert, E.J.W., Ohshima, K.-1., see Ihara, Y. (106) 10 Venables, G.S., Sagar, H.J. and Zeman, A. Oldfors, A., see Ullman, M. (106) 67 The role of magnetic stimulation as a quantifier of motor disabil- Olsson, T., see Hdjeberg, B. (106) 91 ity in patients with multiple sclerosis (106) 31 Osame, M., see Higuchi, I. (106) 60 Kandler, R.H., Jarratt, J.A., Gumpert, E.J.W., Davies-Jones, G.A.B., Venables, G.S. and Sagar, H.J. Parizel, P.M., see Truyen, L. (106) 35 The role of magnetic stimulation in the diagnosis of multiple Perry, E.K., see Cheng, A.V.T. (106) 50 sclerosis (106) 25 Perry, R.H., see Cheng, A.V.T. (106) 50 Kato, H., see Araki, T. (106) 206 Perry, R.H., see Ince, P. (106) 142 Kibata, M., see Ihara, Y. (106) 10 Piccolo, G., see Beghi, E. (106) 213 Kimura, J., see Fukuyama, H. (106) 128 Polinsky, R.J., McRae, A., Baser, S.M. and Dahlstrom, A. Kira, J.-i., Fujihara, K., Itoyama, Y., Goto, I. and Hasuo, K. Antibody in the CSF of patients with multiple system atrophy Leukoencephalopathy in HTLV-I-associated myelopathy /tropi- reacts specifically with rat locus ceruleus (106) 96 cal spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy (106) 41 Ribalta, T., see Graus, F. (106) 82 Kodama, H., see Ihara, Y. (106) 10 Kogure, K., see Araki, T. (106) 206 Sagar, H.J., see Kandler, R.H. (106) 25 Konishi, J., see Fukuyama, H. (106) 128 Sagar, H.J., see Kandler, R.H. (106) 31 Kristensson, K., see Hdjeberg, B. (106) 91 Sahgal, A., see Cheng, A.V.T. (106) 50 Kuriyama, M., see Higuchi, I. (106) 60 Saito, T., see Araki, T. (106) 206 Kuroda, Y. and Sugihara, H. Satoh, K.-i., see Nishimura, M. (106) 19 Autopsy report of HTLV-I-associated myelopathy presenting with Schmitzer-Osborne, S.E., see Landfield, P.W. (106) 221 ALS-like manifestations (106) 199 Senda, M., see Fukuyama, H. (106) 128 Shibayama, K., Nakamura, T., Nagasato, K., Shirabe, S., Tsujihata, Landfield, P.W., Applegate, M.D., Schmitzer-Osborne, S.E. and M. and Nagataki, S. Naylor, C.E. Interferon-alpha treatment in HTLV-I-associated myelopathy. Phosphate /calcium alterations in the first stages of Alzheimer’s Studies of clinical and immunological aspects (106) 186 disease: implications for etiology and pathogenesis (106) 221 Shirabe, S., see Shibayama, K. (106) 186 Laurent, B., see Antoine, J.C. (106) 179 Shirabe, T., see Ihara, Y. (106) 10 Loeb, C., see Tabaton, M. (106) 123 Soriano, E., see Ferrer, I. (106) 135 Lombardi, M., see Beghi, E. (106) 213 Souverijn, J.H.M. Lycke, E., see Hojeberg, B. (106) 91 Reply to the letter by Ohman (J. Neurol. Sci., 106 (1991) 230-231) (106) 221 Mabuchi, H., see Ihara, Y. (106) 10 Suga, M., see Nishimura, M. (106) 19 MacArthur, F., see Ince, P. (106) 142 Sugihara, H., see Kuroda, Y. (106) 199 Mancardi, G., see Tabaton, M. (106) 123 Mantegazza, R., see Beghi, E. (106) 213 Tabaton, M., Caponnetto, C., Mancardi, G. and Loeb, C. Martin, J.J., see Truyen, L. (106) 35 Amyloid beta protein deposition in brains from elderiy subjects Matsuoka, T., Goto, Y.-i., Yoneda, M. and Nonaka, I. with leukoaraiosis (106) 123 Muscle histopathology in myoclonus epilepsy with ragged-red Tanabe, H., see Yokota, T. (106) 175 fibers (MERRF) (106) 193 Tommasi, M., see Antoine, J.C. (106) 179 McKeith, I.G., see Cheng, A.V.T. (106) 50 Tonali, P., see Beghi, E. (106) 213 McRae, A., see Polinsky, R.J. (106) 96 Trevisan, D., see Beghi, E. (106) 213 Michel, D., see Antoine, J.C. (106) 179 Truyen, L., Gheuens, J., Parizel, P.M., Van de Vyver, F.L. and Miyoshi, T., see Fukuyama, H. (106) 128 Martin, J.J. Monticelli, M.L., see Beghi, E. (106) 213 Long term follow-up of muitiple sclerosis by standardized, non- Mori, A., see Ihara, Y. (106) 10 contrast-enhanced magnetic resonance imaging (106) 35 240 Tsuchiya, K., see Yokota, T. (106) 175 Waxman, S.G., see Vollmer, T.L. (106) 153 Tsujihata, M., see Shibayama, K. (106) 186 Tsukagoshi, H., see Yokota, T. (106) 175 Tu, S.-C., see Chu, N.-S. (106) 1 Yamaguchi, S., see Fukuyama, H. (106) 128 Tunon, T., see Ferrer, I. (106) 135 Yamauchi, H., see Fukuyama, H. (106) 128 Yamane, M., see Yokota, T. (106) 175 Ullman, M. and Oldfors, A. Yokota, T., Tsuchiya, K., Yamane, M., Hayashi, M., Tanabe, H. and Skeletal muscle regeneration in young rats is dependent on Tsukagoshi, H. growth hormone (106) 67 Geotropic ocular deviation with skew and absence of saccade in Usuki, F., see Higuchi, I. (106) 60 Creutzfelt-Jakob disease (106) 175 Yoneda, M., see Matsuoka, T. (106) 193 Van den Noort, S., see Frohman, E.M. (106) 105 Yonekura, Y., see Fukuyama, H. (106) 128 Van de Vyver, F.L., see Truyen, L. (106) 35 Venables, G.S., see Kandler, R.H. (106) 25 Venables, G.S., see Kandler, R.H. (106) 31 Zarrelli, M., see Beghi, E. (106) 213 Vollmer, T.L., Brass, L.-M. and Waxman, S.G. Zeman, A., see Kandler, R.H. (106) 31 Lhermitte’s sign in a patient with herpes zoster (106) 153 Zwang, R., see Blansjaar, B.A. (106) 88 Journal of the Neurological Sciences, 106 (1991) 241-242 © 1991 Elsevier Science Publishers B.V. All rights reserved 0022-/5911 /0$03X.5 0 Subject Index (Vol. 106) Acetylcholine, (106) 206 Headache, (106) 75 Adenosine, (106) 206 Hepatolenticular degeneration, (106) 1 Alzheimer’s disease, (106) 50; (106) 105; (106) 123; (106) 135; (106) Hippocampus, (106) 128; (106) 142 221 Hormonal change, (106) 75 Alzheimer-type pathology, (106) 142 HTLV-I, (106) 41 Amyloid beta protein, (106) 123 HTLV-I-associated myelopathy, (106) 41; (106) 186; (106) 199 Amyotrophic lateral sclerosis, (106) 199 Hypophysectomy, (106) 67 Angio-Behget’s syndrome, (106) 19 Immunocytochemistry, (106) 123 Angiography, (106) 19 Immunohistochemistry, (106) 82 Antibody, (106) 96 Inflammation, (106) 158 Autoantibody, (106) 82 Inflammatory myopathy, (106) 60 Autoimmune disease, (106) 82 Insulin, (106) 56 Autoimmunity, (106) 91 Intercellular adhesion molecule-1, (106) 105 Autonomic failure, (106) 96 Interferon-alpha treatment, (106) 186 Autophagic vacuole, (106) 60 Ion-exchange chromatography, (106) 88 Autopsy, (106) 199 Isoelectric focusing, (106) 88 Autoradiography, (106) 206 Ketanserin, (106) 50 Axo-axonic neurons, (106) 135 Leukoaraiosis, (106) 123 Axonal hyperexcitability, (106) 153 Leukoencephalopathy, (106) 41 Basket cells, (106) 135 Lewy body, (106) 142 Behcet’s syndrome, (106) 19 Linoleic acid, (106) 56 Brain, (106) 179 y-Linolenic acid, (106) 56 Brainstem, (106) 179 Lipid peroxide, (106) 10 Calcium antagonist, (106) 206 Locus ceruleus, (106) 96 Calcium-binding proteins, (106) 135 Lymphocyte function-associated antigen-1, (106) 105 Calcium metabolism, (106) 221 Macrophage, (106) 158 Capillaries, (106) 158 Magnetic resonance imaging, (106) 35 CD4-positive T cell, (106) 60 Magnetic resonance imaging (MRI), (106) 19; (106) 41 CD8-positive T cell, (106) 60 Magnetic stimulation, (106) 25; (106) 31 Central motor conduction, (106) 25; (106) 31 MERRF, (106) 193 Cerebral cortex, (106) 135 MHC class I, (106) 60 Cerebral infarction, (106) 10 MHC class II, (106) 60 Cerebral ischemia, (106) 206 Mitochondrial DNA mutation, (106) 193 Cerebrospinal fluid, (106) 96 Mitochondrial encephalomyopathy, (106) 193 Corneal opacity, (106) 10 Molecular mimicry, (106) 91 Creutzfelt-Jakob disease, (106) 175 Monocyte, (106) 10 Cytochrome c oxidase, (106) 193 Motor evoked potential, (106) 25; (106) 31 Dementia, (106) 142 Motor nerve, (106) 56 EEG, (106) 1 Motor neuron disease, (106) 199 EEG spectral analysis, (106) 1 Multicenter follow-up study, (106) 213 EEG topography, (106) 1 Multiple sclerosis, (106) 25; (106) 31; (106) 35 Endocrinology, (106) 221 Multiple system atrophy, (106) 96 Endothelium, (106) 105 Muscle histopathology, (106) 193 Essential fatty acid, (106) 56 Myasthenia gravis, (106) 213 Experimental diabetes, (106) 56 Myelopathy, (106) 153 Facial nerve, (106) 179 Neural conduction, (106) 56 Familial hypercholesterolemia, (106) 10 Neuritic plaque, (106) 105 Follow-up, (106) 35 Neuritis, (106) 91 Free radical, (106) 10 Neuro-Behcet’s syndrome, (106) 19 Geotropic ocular deviation, (106) 175 Neurofibrillary tangles, (106) 142 Gerbil, (106) 206 Neuron, (106) 179 Glucose metabolism, (106) 128 Notexin, (106) 67 Growth hormone, (106) 67 Occlusive panarteritis, (106) 19 Guinea pig, (106) 158 Paraneoplastic cerebellar degeneration, (106) 82 242 Parkinson’s disease, (106) 50 Serotonin, (106) 50 Parvalbumin, (106) 135 Serotonin receptor, (106) 50 Peripheral neuropathy, (106) 179 Shingles, (196) 153 Perivascular space, (106) 158 Skeletal muscle, (106) 67 - Phosphate, (106) 221 Skew deviation, (106) 175 Polyneuropathy, (106) 10 Spinal cord, (106) 179 Positron emission tomography, (106) 128 Spinal cord disease, (106) 153 Pretectal area, (106) 175 Spinal cord trauma, (106) 158 Probucol, (106) 10 Spontaneous proliferation of peripheral blood lymphocyte, (106) 186 Prognosis, (106) 213 Streptozotocin, (106) 56 Rats, (106) 67 Surgery, (106) 213 Reconstruction, (106) 128 Syringomyelia-like syndrome, (106) 179 Regeneration, (106) 67 Tangier disease, (106) 179 Roots, (106) 179 Temporal lobe, (106) 128 Saccade, (106) 175 Therapy, (106) 213 Satellite cells, (106) 67 Thymidine, (106) 67 Secondary pathology, (106) 158 Transketolase, (106) 88 Selectively vulnerable areas, (106) 206 Tropical spastic paraparesis, (106) 199 Senile dementia of Lewy body type, (106) 50 Wernicke—Korsakoff syndrome, (106) 88 Senile plaques, (106) 142 Wilson’s disease, (106) 1 Sensory nerve, (106) 56